South Korean doctors strike condemning government reforms
Seoul: On Friday, South Korea’s top medical body faced resentment from trainee doctors. The rift arose as the trainee doctors...
Latest Post
Eli Lilly and Amgen unites to produce COVID-19 antibody therapies
THD News desk, New Delhi: On 18th of September, Eli Lily and Amgen, two of the pharmaceutical giants have announced...
China likely rejecting lawsuits of families of Covid-19 victims
Wuhan: The lives claimed by Coronavirus in Wuhan are being rejected of the due lawsuits by the government, according to...
CCI approves Piramal-Carlyle merger, closes deal at 3700 Crores
THD NewsDesk, NEW DELHI: The Competition Commission of India (CCI) has finally approved the amalgamation of Piramal Pharma Ltd and...
New study in Cancer; indication of response to immunotherapy
THD NewsDesk, MASSACHUSETTS: A research team comprising of scientists from Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) have...
Punjab’s Success Story: A Blueprint for Achieving the Highest Recovery Rate in a Month
THD NewsDesk, CHANDIGARH: Punjab has dramatically turned the tables by attaining a 92% recovery rate - the highest in the...
Health Systems Across Countries Face Adverse Repercussions of COVID-19, Says WHO
THD NewsDesk, GENEVA: In a recent survey released by the WHO, it was discovered that health services stand disrupted in most...
WHO Approves Corticosteroids for Severe COVID-Positive Patients
THD NewsDesk, GENEVA: On the 2nd of September, the World Health Organisation released its guidance for clinicians and healthcare decision...
India Faces Acute Oxygen Shortage as Pandemic Spreads Its Tentacles Further
THD NewsDesk, NEW DELHI: According to the recent BBC India report published on 15th September by Soutik Biswas, India is...
Zydus Cadila Receives USFDA’s Approval to Commercialize Empagliflozin and Linagliptin Tablets
THD NewsDesk, AHMEDABAD: International drug firm Zydus Cadila has received permission from the US Food and Drug Administration (USFDA) to...
